G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $374,588 | -53.5% | 150,437 | -50.0% | 0.00% | -63.6% |
Q1 2023 | $806,342 | -85.6% | 300,874 | -70.8% | 0.01% | -85.3% |
Q4 2022 | $5,587,291 | +61.6% | 1,028,967 | +271.6% | 0.08% | +56.2% |
Q3 2022 | $3,458,000 | -61.0% | 276,900 | -84.6% | 0.05% | -65.0% |
Q2 2022 | $8,878,000 | – | 1,797,182 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |